Weekly Briefing for November 8 to 14, 2026

NOV 15, 20264 MIN

Description

A workgroup convened by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) rated F-18 floretyrosine (FET) PET appropriate for glioma biopsy planning and for separating tumor from treatment-related changes. Bracco and Avicenna.AI announced Food and Drug Administration (FDA) clearance of brain aneurysm detection software, Clarity Pharmaceuticals reported a breakthrough designation for a PSMA PET agent, the American Cancer Society tied prostate biopsy decisions to MRI, and the FDA posted an Arrow guidewire alert. Read this week's roundup and its sources: https://physicianintheloop.org/specialties/radiology/2026-11-08/ Get this roundup by email, free The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.